HGG-21. GERMLINE MUTATIONS IN MSH2 GENE IN PEDIATRIC PATIENTS WITH CONGENITAL AND SPORADIC GLIOBLASTOMA

INTRODUCTION: Glioblastoma (GBM) remains one of the biggest therapeutic challenges in neuro-oncology. In spite of multimodal treatment approaches the prognosis of GBM is extremely poor, median survival is estimated about 12–16 months. Although GBM is one of the most common and malignant primary brai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Ejmont, Maria, Rydzanicz, Małgorzata, Grajkowska, Wiesława, Perek-Polnik, Marta, Sowińska, Agnieszka, Kozłowska, Magdalena, Łastowska, Maria, Pronicki, Maciej, Płoski, Rafał, Dembowska-Bagińska, Bożenna, Trubicka, Joanna
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
High Grade Glioma
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715741/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.308
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados